NO165393C - Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre. - Google Patents
Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre.Info
- Publication number
- NO165393C NO165393C NO864635A NO864635A NO165393C NO 165393 C NO165393 C NO 165393C NO 864635 A NO864635 A NO 864635A NO 864635 A NO864635 A NO 864635A NO 165393 C NO165393 C NO 165393C
- Authority
- NO
- Norway
- Prior art keywords
- salts
- preparation
- aryloxypropanolamines
- diphenyledic
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title 3
- 150000003839 salts Chemical class 0.000 abstract 3
- WBJWXIQDBDZMAW-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carbonyl chloride Chemical compound C1=CC=CC2=C(C(Cl)=O)C(O)=CC=C21 WBJWXIQDBDZMAW-UHFFFAOYSA-N 0.000 abstract 1
- PYHXGXCGESYPCW-UHFFFAOYSA-N alpha-phenylbenzeneacetic acid Natural products C=1C=CC=CC=1C(C(=O)O)C1=CC=CC=C1 PYHXGXCGESYPCW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853544172 DE3544172A1 (de) | 1985-12-13 | 1985-12-13 | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO864635D0 NO864635D0 (no) | 1986-11-20 |
| NO864635L NO864635L (no) | 1987-06-15 |
| NO165393B NO165393B (no) | 1990-10-29 |
| NO165393C true NO165393C (no) | 1991-02-06 |
Family
ID=6288400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO864635A NO165393C (no) | 1985-12-13 | 1986-11-20 | Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4767784A (cs) |
| EP (1) | EP0229947B1 (cs) |
| JP (1) | JPS62155238A (cs) |
| AT (1) | ATE61573T1 (cs) |
| CS (1) | CS259896B2 (cs) |
| DD (1) | DD262426A1 (cs) |
| DE (2) | DE3544172A1 (cs) |
| DK (1) | DK597786A (cs) |
| ES (1) | ES2020925B3 (cs) |
| FI (1) | FI864970A7 (cs) |
| GR (1) | GR3001691T3 (cs) |
| HU (1) | HU206669B (cs) |
| NO (1) | NO165393C (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
| AU5839000A (en) * | 1999-07-30 | 2001-02-19 | Ranbaxy Laboratories Limited | An improved form of form i celiprolol hydrochloride |
| TWI316511B (en) | 2002-11-26 | 2009-11-01 | Smithkline Beecham Corp | Calcilytic compounds |
| ITMI20040145A1 (it) * | 2004-01-30 | 2004-04-30 | Acraf | L-moprololo lpiu' tartrato |
| EP1723107A2 (en) | 2004-02-23 | 2006-11-22 | Cadila Healthcare Ltd. | Process for manufacture of racemic carvedilol |
| US8022094B2 (en) * | 2006-06-28 | 2011-09-20 | Teva Pharmaceutical Industries Ltd. | Carvedilol phosphate |
| GB2442238B (en) * | 2006-09-29 | 2008-10-01 | Rolls Royce Plc | Sheet metal blank |
| CN110662543A (zh) | 2017-03-23 | 2020-01-07 | 灰色视觉公司 | 用于治疗眼部疾病的药物和组合物 |
| GB2593902B (en) * | 2020-04-07 | 2022-04-13 | Actimed Therapeutics Ltd | Salt of a pharmaceutical compound |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB448181A (en) * | 1934-07-12 | 1936-05-25 | Chem Ind Basel | Manufacture of basic esters of polyarylacetic acids |
| US2517856A (en) * | 1949-05-12 | 1950-08-08 | Kay Fries Chemicals Inc | Method of preparing diphenyl acetic acid |
| NL301580A (cs) * | 1962-12-11 | |||
| NL131194C (cs) * | 1963-07-19 | |||
| CA956632A (en) * | 1969-05-16 | 1974-10-22 | Yoshitomi Pharmaceutical Industries | Phenoxy-aminopropanol derivatives |
| US4038313A (en) * | 1970-01-08 | 1977-07-26 | Ciba-Geigy Corporation | Cycloalkylureido phenoxy propanolamines |
| NL7115581A (cs) * | 1970-11-13 | 1972-05-16 | Dresden Arzneimittel | |
| GB1396322A (en) * | 1971-06-15 | 1975-06-04 | Ici Ltd | Alkanolamine derivatives |
| HU167262B (cs) * | 1972-12-22 | 1975-09-27 | ||
| AT335465B (de) * | 1974-11-20 | 1977-03-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen 3-(p-ureidophenoxy)-2-hydroxy-aminopropanen sowie deren saureadditionssalzen |
| AT334385B (de) * | 1973-12-20 | 1976-01-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen |
| HU170678B (cs) * | 1973-12-20 | 1977-08-28 | ||
| AT335464B (de) * | 1974-11-19 | 1977-03-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen 3-(p-ureidophenoxy)-2-hydroxy-aminopropanen sowie deren saureadditionssalzen |
| SE388849B (sv) * | 1974-02-14 | 1976-10-18 | Haessle Ab | Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| AT350539B (de) * | 1976-02-09 | 1979-06-11 | Squibb & Sons Inc | Verfahren zur herstellung von neuen 4-(3-subst. amino-2-hydroxpropoxy)-5,6,7,8-tetrahydro- 1,6,7-naphthalintriolen |
| SE7807408L (sv) * | 1978-06-30 | 1979-12-31 | Haessle Ab | Hjertaktiva foreningar |
| US4294966A (en) * | 1978-07-28 | 1981-10-13 | Ciba-Geigy Corporation | Process for inverting the configuration in optically active compounds |
| DE3200304A1 (de) * | 1981-01-16 | 1982-08-26 | Sandoz-Patent-GmbH, 7850 Lörrach | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel |
| US4404213A (en) * | 1981-01-26 | 1983-09-13 | Shell Oil Company | Derivatives of certain pyridyliminomethyl-benzenes |
| DE3309595A1 (de) * | 1983-03-17 | 1984-09-20 | Basf Ag, 6700 Ludwigshafen | Neue aminopropanolderivate von 1-(2-hydroxy-phenyl)-3-phenyl-propanolen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel |
| DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
-
1985
- 1985-12-13 DE DE19853544172 patent/DE3544172A1/de not_active Withdrawn
-
1986
- 1986-11-20 NO NO864635A patent/NO165393C/no unknown
- 1986-11-28 US US06/935,917 patent/US4767784A/en not_active Expired - Fee Related
- 1986-12-02 DE DE8686116703T patent/DE3678139D1/de not_active Expired - Fee Related
- 1986-12-02 AT AT86116703T patent/ATE61573T1/de not_active IP Right Cessation
- 1986-12-02 CS CS868843A patent/CS259896B2/cs unknown
- 1986-12-02 ES ES86116703T patent/ES2020925B3/es not_active Expired - Lifetime
- 1986-12-02 EP EP86116703A patent/EP0229947B1/de not_active Expired - Lifetime
- 1986-12-05 FI FI864970A patent/FI864970A7/fi not_active IP Right Cessation
- 1986-12-10 DD DD86297387A patent/DD262426A1/de unknown
- 1986-12-12 DK DK597786A patent/DK597786A/da not_active Application Discontinuation
- 1986-12-12 JP JP61295103A patent/JPS62155238A/ja active Pending
- 1986-12-12 HU HU865204A patent/HU206669B/hu not_active IP Right Cessation
-
1988
- 1988-06-06 US US07/203,390 patent/US4849530A/en not_active Expired - Fee Related
-
1991
- 1991-03-29 GR GR91400401T patent/GR3001691T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK597786A (da) | 1987-06-14 |
| CS259896B2 (en) | 1988-11-15 |
| EP0229947A1 (de) | 1987-07-29 |
| ES2020925B3 (es) | 1991-10-16 |
| CS884386A2 (en) | 1987-11-12 |
| ATE61573T1 (de) | 1991-03-15 |
| GR3001691T3 (en) | 1992-11-23 |
| FI864970L (fi) | 1987-06-14 |
| US4849530A (en) | 1989-07-18 |
| NO165393B (no) | 1990-10-29 |
| DE3544172A1 (de) | 1987-06-19 |
| JPS62155238A (ja) | 1987-07-10 |
| DD262426A1 (de) | 1988-11-30 |
| DE3678139D1 (de) | 1991-04-18 |
| EP0229947B1 (de) | 1991-03-13 |
| FI864970A7 (fi) | 1987-06-14 |
| NO864635D0 (no) | 1986-11-20 |
| NO864635L (no) | 1987-06-15 |
| FI864970A0 (fi) | 1986-12-05 |
| HU206669B (en) | 1992-12-28 |
| DK597786D0 (da) | 1986-12-12 |
| HUT46292A (en) | 1988-10-28 |
| US4767784A (en) | 1988-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI892603A7 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 4-(kinolin-2-yylimetoksi)fenyylietikkahappojohdannaisten valmistamiseksi | |
| FI861505A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi | |
| FI873467A7 (fi) | Menetelmä 5-amino-4-hydroksivaleriaanahappojohdannaisten valmistamiseksi | |
| FI875660L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi | |
| FI890508L (fi) | Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi | |
| FI875024A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1-alkyyli-6-halogeenitetrahydronaftaleenijohdannaisten valmistamiseksi | |
| NO851643L (no) | 1,4-dihydro-4-oksonafthyridin-derivater og salter derav, fremgangsmaate til fremstilling av forbindelsene og antibakterielle midler som innbefatter disse | |
| NO860332L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. | |
| PT87153A (pt) | Process for the preparation of acid ribofuranuronic derivatives | |
| NO165393C (no) | Fremgansmaate for fremstilling av aryloksypropanolaminer og salter av disse med difenyleddiksyre. | |
| FI871087A0 (fi) | Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi | |
| NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
| FI892946A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
| FI900145L (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi | |
| FI890477L (fi) | Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi | |
| FI893682L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi | |
| FI863471A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi | |
| FI883248A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi | |
| SE8101963L (sv) | Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav | |
| FI864615A7 (fi) | Menetelmä farmakologisesti aktiivisten -(aminoalkyyli)-aryylietikkahappojohdannaisten valmistamiseksi. | |
| FI922125A7 (fi) | Mikrobiologinen menetelmä 5-hydroksipyratsiinikarboksyylihapon valmistamiseksi | |
| AR243159A1 (es) | Procedimiento de preparacion de acido 1-(3-mercapto-(2s)-metilpropionil)-pirrolidin-(2s)-carboxilico o sus sales farmaceuticamente aceptables. | |
| FI881032A7 (fi) | Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi. | |
| FI922268L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten N-difenyylialkyylialkoksisubstituoitujen 3-piperidiinikarboksyylihappojohdannaisten valmistamiseksi | |
| FI862279A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten N-fenyyli-4-fenyyli-1 -piperatsiinikarboksamidijohdannaisten valmistamiseksi. |